BRIUMVI

ublituximab · TG Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for BRIUMVI, covering 2022-12-28 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk